万孚生物
(300482)
| 流通市值：91.16亿 | | | 总市值：99.14亿 |
| 流通股本：4.30亿 | | | 总股本：4.68亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 205,184,946.58 | 343,670,598.96 | 306,674,463.35 | 828,694,440.3 |
| 结算备付金 | 0 | - | - | 0 |
| 拆出资金 | 0 | - | - | 0 |
| 交易性金融资产 | 1,406,465,140.66 | 1,261,537,727.88 | 1,627,842,295.03 | 1,306,263,430.34 |
| 衍生金融资产 | 0 | - | - | 0 |
| 应收票据及应收账款 | 1,075,823,510.7 | 1,223,778,055.62 | 1,392,438,171.49 | 1,130,070,697.88 |
| 其中：应收票据 | 30,205,140.02 | 34,202,155.16 | 27,575,749.01 | 14,585,892.87 |
| 应收账款 | 1,045,618,370.68 | 1,189,575,900.46 | 1,364,862,422.48 | 1,115,484,805.01 |
| 应收款项融资 | 0 | - | - | 0 |
| 预付款项 | 16,527,839.56 | 17,129,899.46 | 18,901,287.64 | 17,936,234.99 |
| 应收保费 | 0 | - | - | 0 |
| 应收分保账款 | 0 | - | - | 0 |
| 应收分保合同准备金 | 0 | - | - | 0 |
| 其他应收款合计 | 87,200,795.28 | 78,780,919.11 | 57,473,556.91 | 44,252,354.99 |
| 其中:应收利息 | 0 | - | - | 0 |
| 应收股利 | 0 | - | - | 0 |
| 买入返售金融资产 | 0 | - | - | 0 |
| 存货 | 346,489,631.92 | 347,358,937.24 | 319,592,386.44 | 359,555,274.55 |
| 合同资产 | 0 | - | - | 0 |
| 一年内到期的非流动资产 | 0 | - | - | 0 |
| 其他流动资产 | 137,575,046.47 | 110,806,277 | 101,751,881.18 | 99,089,532.75 |
| 流动资产合计 | 3,275,266,911.17 | 3,383,062,415.27 | 3,824,674,042.04 | 3,785,861,965.8 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | - | 0 |
| 债权投资 | 885,058,163.65 | 1,036,543,589.68 | 885,572,017.07 | 882,042,591.22 |
| 其他债权投资 | 0 | - | - | 0 |
| 长期应收款 | 0 | - | - | 0 |
| 长期股权投资 | 406,175,169 | 407,858,152.95 | 419,319,132.15 | 425,385,597.66 |
| 其他权益工具投资 | 111,997,538.21 | 95,423,435.76 | 83,602,848.22 | 83,602,848.22 |
| 其他非流动金融资产 | 0 | - | - | 0 |
| 投资性房地产 | 0 | - | - | 0 |
| 固定资产 | 1,456,853,768.45 | 1,450,304,177.95 | 1,457,458,123.07 | 1,460,725,519.7 |
| 在建工程 | 14,541,830.26 | 9,471,589.56 | 7,287,373.94 | 5,122,811.19 |
| 生产性生物资产 | 0 | - | - | 0 |
| 油气资产 | 0 | - | - | 0 |
| 使用权资产 | 13,340,415.58 | 14,844,980.83 | 16,237,077.47 | 17,750,009.64 |
| 无形资产 | 225,099,561.25 | 224,119,955.96 | 225,338,415.24 | 205,509,612.78 |
| 开发支出 | 55,232,653.87 | 63,693,557.36 | 40,177,335.13 | 40,370,356.33 |
| 商誉 | 111,418,791.83 | 111,418,791.83 | 111,418,791.83 | 111,418,791.83 |
| 长期待摊费用 | 11,356,374.15 | 13,559,297.52 | 15,163,288.97 | 16,091,191.4 |
| 递延所得税资产 | 71,227,275.42 | 74,307,084.48 | 76,748,798.52 | 76,175,949.66 |
| 其他非流动资产 | 14,945,877.66 | 15,421,693.85 | 19,548,668.88 | 44,594,797.7 |
| 非流动资产合计 | 3,377,247,419.33 | 3,516,966,307.73 | 3,357,871,870.49 | 3,368,790,077.33 |
| 资产总计 | 6,652,514,330.5 | 6,900,028,723 | 7,182,545,912.53 | 7,154,652,043.13 |
| 流动负债: | | | | |
| 短期借款 | 7,000 | 1,710,000 | 42,209.92 | 755,433.59 |
| 向中央银行借款 | 0 | - | - | 0 |
| 吸收存款及同业存放 | 0 | - | - | 0 |
| 拆入资金 | 0 | - | - | 0 |
| 交易性金融负债 | 0 | - | - | 0 |
| 衍生金融负债 | 0 | - | - | 0 |
| 应付票据及应付账款 | 253,426,744.48 | 271,167,484.7 | 237,408,940.26 | 288,365,936.22 |
| 其中：应付票据 | 0 | - | - | 0 |
| 应付账款 | 253,426,744.48 | 271,167,484.7 | 237,408,940.26 | 288,365,936.22 |
| 预收款项 | 0 | - | - | 0 |
| 合同负债 | 71,778,224.9 | 64,936,695.8 | 63,125,813.25 | 77,095,198.16 |
| 卖出回购金融资产款 | 0 | - | - | 0 |
| 应付手续费及佣金 | 0 | - | - | 0 |
| 应付职工薪酬 | 45,094,269.88 | 66,932,529.12 | 77,634,396.62 | 161,555,706.01 |
| 应交税费 | 7,438,010.43 | 12,869,420.05 | 57,013,807.58 | 60,155,234.38 |
| 其他应付款合计 | 31,441,955.76 | 162,217,448.75 | 214,594,380.56 | 225,134,464.01 |
| 其中:应付利息 | 0 | - | - | 0 |
| 应付股利 | 0 | - | - | 0 |
| 应付分保账款 | 0 | - | - | 0 |
| 保险合同准备金 | 0 | - | - | 0 |
| 代理买卖证券款 | 0 | - | - | 0 |
| 代理承销证券款 | 0 | - | - | 0 |
| 一年内到期的非流动负债 | 5,005,520.61 | 5,367,806.95 | 5,559,873.39 | 5,412,200.02 |
| 其他流动负债 | 7,008,427.95 | 6,576,580.48 | 6,166,692.34 | 2,989,968.61 |
| 流动负债合计 | 421,200,154.01 | 591,777,965.85 | 661,546,113.92 | 821,464,141 |
| 非流动负债: | | | | |
| 长期借款 | 0 | - | - | 0 |
| 应付债券 | 581,258,213.47 | 584,933,848.87 | 577,958,159.25 | 570,972,469.63 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 租赁负债 | 10,246,635.68 | 11,289,277.42 | 12,705,890.29 | 14,331,183.88 |
| 长期应付款 | 0 | - | - | 0 |
| 长期应付职工薪酬 | 0 | - | - | 0 |
| 预计负债 | 0 | - | - | 0 |
| 递延收益 | 39,152,065.35 | 42,443,884 | 45,438,982.67 | 47,938,519.63 |
| 递延所得税负债 | 40,174,218.06 | 42,180,259.86 | 44,673,486.2 | 49,657,723.4 |
| 其他非流动负债 | 0 | - | - | 0 |
| 非流动负债合计 | 670,831,132.56 | 680,847,270.15 | 680,776,518.41 | 682,899,896.54 |
| 负债合计 | 1,092,031,286.57 | 1,272,625,236 | 1,342,322,632.33 | 1,504,364,037.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 468,084,798 | 478,628,761 | 481,424,354 | 481,424,317 |
| 其他权益工具 | 107,449,333.58 | 107,449,513.35 | 107,451,490.87 | 107,451,670.64 |
| 资本公积 | 1,305,900,909.58 | 1,426,312,246.81 | 1,458,229,996.29 | 1,458,338,833.52 |
| 减:库存股 | 275,729 | 135,758,880 | 171,018,800 | 171,018,800 |
| 其他综合收益 | -128,809,471 | -128,780,612.95 | -128,771,235.83 | -128,743,268.39 |
| 专项储备 | 0 | - | - | 0 |
| 盈余公积 | 261,061,579.09 | 261,061,579.09 | 261,061,579.09 | 261,061,579.09 |
| 一般风险准备 | 0 | - | - | 0 |
| 未分配利润 | 3,487,043,631.82 | 3,542,502,742.11 | 3,735,009,121.13 | 3,545,873,710.98 |
| 归属于母公司股东权益合计 | 5,500,455,052.07 | 5,551,415,349.41 | 5,743,386,505.55 | 5,554,388,042.84 |
| 少数股东权益 | 60,027,991.86 | 75,988,137.59 | 96,836,774.65 | 95,899,962.75 |
| 股东权益合计 | 5,560,483,043.93 | 5,627,403,487 | 5,840,223,280.2 | 5,650,288,005.59 |
| 负债和股东权益合计 | 6,652,514,330.5 | 6,900,028,723 | 7,182,545,912.53 | 7,154,652,043.13 |
| 公告日期 | 2025-10-27 | 2025-08-20 | 2025-04-25 | 2025-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |